Systemic administration of recombinant transforming growth factor beta 2 (rTGF-β2) stimulates parameters of cancellous bone formation in juvenile and adult rats
- 1 May 1994
- Vol. 15 (3) , 355-359
- https://doi.org/10.1016/8756-3282(94)90300-x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Differential chemotactic responses of different populations of fetal rat calvaria cells to platelet-derived growth factor and transforming growth factor βBone and Mineral, 1992
- Rapid publication TGF-β1 induces bone closure of skull defectsJournal of Bone and Mineral Research, 1991
- In vivo induction of bone by recombinant human transforming growth factor β1Journal of Bone and Mineral Research, 1991
- Modified Giemsa Stain for Polymethyl Methacrylate Embedded Undecalcified Bone and Bone Marrow SpecimensJournal of Histotechnology, 1991
- Effects of transforming growth factor β1 on the regulation of osteoclastic development and functionJournal of Bone and Mineral Research, 1991
- Prostaglandin E2 inhibits formation of osteoclastlike cells in long-term human marrow cultures but is not a mediator of the inhibitory effects of transforming growth factor βJournal of Bone and Mineral Research, 1990
- Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur.The Journal of cell biology, 1990
- Transforming Growth Factor-β Stimulates Bone Matrix Apposition and Bone Cell Replication in Cultured Fetal Rat Calvariae*Endocrinology, 1990
- Transforming Growth Factor-β in the Regulation of Fracture RepairOrthopedic Clinics of North America, 1990
- Human Platelet-Derived Transforming Growth Factor-βStimulates Parameters of Bone Growth in Fetal Rat Calvariae*Endocrinology, 1986